• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. GASTROINTESTINAL VIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. GASTROINTESTINAL VIDEOSCOPE Back to Search Results
Model Number GIF-H170
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Perforation (2001)
Event Date 03/19/2021
Event Type  Injury  
Event Description
It is reported in the literature article titled ¿usefulness of fluoroscopy for endoscopic balloon dilation of crohn's disease-related strictures¿; a patient experienced a perforation during a procedure using one of four olympus scopes.Case with patient identifier (b)(6) reports gif-q160, case with patient identifier (b)(6) reports pcf-h180, case with patient identifier (b)(6) reports gif-h160, case with patient identifier (b)(6) reports pcf-q160.Background: fluoroscopy is often used for endoscopic balloon dilation (ebd) of crohn's disease (cd)-related strictures.However, its benefit remains unclear.Aims: to compare ebd with (ebdf) and without (ebdnf) fluoroscopic guidance in cd patients with strictures.Methods: single-center, nested, case-control retrospective study of ebd for cd-related strictures.Technical and clinical success and safety outcomes were compared between ebdf and ebdnf.Results: a total of 122 strictures in 114 cd patients who underwent ebd from 2010 to 2018 at a single institution were reviewed (44 patients ebdf vs.70 ebdnf).Esophagogastroduodenoscopy was the approach in 8 strictures, colonoscopy in 86, and deep enteroscopy in 28.There were no significant differences in the rates of technical and clinical success, need for repeat dilation and surgery between the two groups, although the mean maximal endoscopic balloon diameter was larger in the ebdnf group (17.1 ± 1.9 vs.14.1 ± 2.5; p < 0.001).There was one perforation in ebdf and no serious complications in ebdnf.In multivariate analysis, balloon size < 15 mm (odds ratio [or] 6.388; 95% ci 1.96-20.79; p = 0.002) and multiple strictures (or 3.897; 95% ci 1.09-14.01; p = 0.037) were associated with repeat ebd, and age < 50 years (or 7.178; 95% ci 1.38-37.44; p = 0.019) and small bowel (vs.Colon) location (or 7.525; 95% ci 1.51-37.47; p = 0.014) were associated with the need for surgery after ebd.Conclusions: ebd for cd-related strictures can be performed safely and effectively without fluoroscopic guidance.Balloon size, patient age, stricture location, and multiplicity are associated with clinical success and avoidance of surgery.There was only one serious adverse event, a perforation which occurred in one patient who underwent dilation under fluoroscopy.There were no patient¿s who developed severe bleeding or required hospitalization for pain after balloon dilation in either group.There is no report of any olympus device malfunction reported in any procedure described in this literature.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GASTROINTESTINAL VIDEOSCOPE
Type of Device
GASTROINTESTINAL VIDEOSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
MDR Report Key14641703
MDR Text Key293614893
Report Number2951238-2022-00423
Device Sequence Number1
Product Code FDS
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial
Report Date 05/10/2022,06/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/09/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGIF-H170
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date05/10/2022
Event Location Hospital
Date Report to Manufacturer05/10/2022
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-